Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.

Published date: |
Estimated read time: |
Authored by:
  • AdventHealth Research Institute
Topics:
Care Community

Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt sleep and concentration, negatively impacting daily quality of life and mental health. There is currently no cure.

That is why the AdventHealth Research Institute is excited to be participating in a new multi-site clinical trial funded by the U.S. Department of Defense. Under the leadership of Principal Investigator Michael Seidman, MD, this study will evaluate the efficacy of etanercept, a TNF-alpha blocker, as a potential treatment for blast-induced tinnitus. Click the button below to learn more.

Learn More

Recent News

News

Alcohol, Marijuana and Type 1 Diabetes:

Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...

Read Article
News

The Science That Moves Medicine Forward:

Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...

Read Article
News

Advancing Cancer Research Closer to Home

At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...

Read Article
News

Moving More, Managing Better

For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.

Read Article